Effects of berberine on serum levels of inflammatory factors and inflammatory signaling pathway in obese mice induced by high fat diet

Zhongguo Zhongyao Zazhi

Volumn 35, Issue 11, 2010, Pages 1474-1477

  Shang, Wenbin ^a   Liu, Jia ^a   Yu, Xizhong ^b   Zhao, Juan ^a  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b NANJING NORMAL UNIVERSITY   (China)

Author keywords

Berberine; IKK; Inflammatory cytokine; Insulin resistance

Indexed keywords

ADIPONECTIN; BERBINE DERIVATIVE; I KAPPA B KINASE BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; BERBERINE; FAT INTAKE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; EPIDIDYMIS FAT; INFLAMMATION; LIPID DIET; LIVER; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PROTEIN BLOOD LEVEL; WESTERN BLOTTING; ANIMAL; BLOOD; DISEASE MODEL; DRUG EFFECTS; FAT INTAKE; GLUCOSE TOLERANCE TEST; HUMAN; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; SIGNAL TRANSDUCTION;

ANIMALS; BERBERINE; DIETARY FATS; DISEASE MODELS, ANIMAL; GLUCOSE TOLERANCE TEST; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; LIVER; MALE; MICE; MICE, OBESE; OBESITY; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77956108839     PISSN: 10015302     EISSN: None     Source Type: Journal    
DOI: 10.4268/cjcmm20101125     Document Type: Article

References (18)

1. Shoelson S E, Lee J, Goldfine A B. Inflammation and insulin resistance[J]. J Clin Invest, 2006, 116(7):1793.
2. Dandona P, Aljada A, Bandyopadhyay A. Inflammation: The link between insulin resistance, obesity and diabetes[J]. Trends Immunol, 2004, 25(1):4.
3. Wellen K E, Hotamisligil G S. Inflammation, stress, and diabetes[J]. J Clin Invest, 2005, 115(5):1111.
4. Kim K S, Rhee H I, Park E K, et al. Anti-inflammatory effects of Radix Gentianae Macrophyllae (Qinjiao), Rhizoma Coptidis (Huanglian) and Citri Unshiu Pericarpium (Wenzhou migan) in animal models[J]. Chin Med, 2008, 3:10.
5. Hayashi K, Minoda K, Nagaoka Y, et al. Antiviral activity of berberine and related compounds against human cytomegalovirus [J]. Bioorg Med Chem Lett, 2007, 17(6):1562.
6. Zhou J Y, Zhou S W, Zhang K B, et al. Chronic effects of berberine on blood, liver glucolipid metabolism and liver PPARs expression in diabetic hyperlipidemic rats[J]. Biol Pharm Bull, 2008, 31(6):1169.
7. Yin J, Gao Z, Liu D, et al. Berberine improves glucose metabolism through induction of glycolysis[J]. Am J Physiol Endocrinol Metab, 2008, 294(1):E148.
8. Shoelson S E, Lee J, Yuan M. Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance[J]. Int J Obes Relat Metab Disord, 2003, 27(3): S49.
9. Calabro P, Yeh E T. Obesity, inflammation, and vascular disease: The role of the adipose tissue as an endocrine organ[J]. Subcell Biochem, 2007, 42:63.
10. de Luca C, Olefsky J M. Inflammation and insulin resistance [J]. FEBS Lett, 2008, 582(1):97.
11. Hotamisligil G S, Arner P, Caro J F, et al. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance[J]. J Clin Invest, 1995,95(5):2409.
12. Spiegelman B M, Hotamisligil G S. Through thick and thin: Wasting, obesity, and TNF alpha[J]. Cell, 1993, 73(4):625.
13. Krag M B, Rasmussen L M, Hansen T K, et al. Peroxisome proliferator-activated receptor gamma (PPAR) agonism reduces the insulin-stimulated increase in circulating interleukin-6 in GH replaced GH-deflcient adults[J]. Clin Endocrinol (Oxf), 2009, 71(3):363.
14. Yuan M, Konstantopoulos N, Lee J, et al. Reversal of obesity-and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta[J]. Science, 2001, 293(5535):1673.
15. Fantuzzi G. Adipose tissue, adipokines, and inflammation[J]. J Allergy Clin Immunol, 2005, 115(5):911.
16. Ruan H, Pownall H J. The adipocyte IKK/NFkappaB pathway: A therapeutic target for insulin resistance[J]. Curr Opin Investig Drugs, 2009, 10(4):346.